Quality Use of Medicines and Medicines Safety

The Commission is currently engaging stakeholders to provide feedback on the Quality Use of Medicines and Medicines Safety Discussion Paper.

In November 2019, the Council of Australian Governments (COAG) Health Council made Quality Use of Medicines and Medicines Safety the 10th National Health Priority Area. The Commission was subsequently engaged to develop a national baseline report on the Quality Use of Medicines and Medicines Safety, with an initial focus on aged care. To assist in the development of this report, the Commission is seeking input from clinicians, consumers, carers, service providers and other stakeholders in the aged care sector to inform the development of the report. The Quality Use of Medicines and Medicines Safety Discussion Paper has been published in support of the public consultation.

The public consultation is open during August and September 2020 and responses are due by close-of-business Friday 2 October 2020. Responses can be made via email to medsafety@safetyandquality.gov.au or via Survey Monkey.

The Discussion Paper focuses on polypharmacy, use of antipsychotic medicines and transitions of care in aged care. Stakeholders are asked to consider four key questions in relation to these focus areas:

  • What is considered best practice in 2020?
    • What works and should be done more?
    • What doesn’t work and should be done less?
  • What are the system-wide challenges that need to be addressed?
  • What are the gaps in current processes that inhibit achieving positive patient outcomes/best practice?
  • How should we monitor progress towards quality and safe use of medicines in hospital patients who are residents in aged care facilities?